Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,085 INR | +0.32% | -2.54% | +0.08% |
Feb. 02 | Ajanta Pharma Posts Gains in Fiscal Q3 Consolidated Net Profit | MT |
Jan. 31 | Transcript : Ajanta Pharma Limited, Q3 2024 Earnings Call, Jan 31, 2024 |
Sales 2024 * | 42.01B 504M | Sales 2025 * | 47.09B 565M | Capitalization | 263B 3.15B |
---|---|---|---|---|---|
Net income 2024 * | 8.08B 96.96M | Net income 2025 * | 9.5B 114M | EV / Sales 2024 * | 6.06 x |
Net cash position 2024 * | 7.97B 95.65M | Net cash position 2025 * | 13.8B 166M | EV / Sales 2025 * | 5.28 x |
P/E ratio 2024 * |
32.9
x | P/E ratio 2025 * |
27.7
x | Employees | 7,713 |
Yield 2024 * |
0.97% | Yield 2025 * |
0.8% | Free-Float | 50.31% |
Latest transcript on Ajanta Pharma Limited
1 day | +0.32% | ||
1 week | -2.54% | ||
Current month | -6.52% | ||
1 month | -1.84% | ||
3 months | -5.81% | ||
6 months | +16.31% | ||
Current year | +0.08% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 98-12-31 | |
Chief Executive Officer | 52 | 95-12-31 | |
Director of Finance/CFO | 59 | 98-04-22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 52 | 95-12-31 | |
Chairman | 77 | 79-12-30 | |
Director/Board Member | 78 | 08-10-19 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 4 M€ | -4.41% | - | |
0.00% | 117 M€ | -1.55% | - | |
0.00% | 34 M€ | +1.25% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 2,085 | +0.32% | 34,465 |
24-04-18 | 2,079 | +0.67% | 55,956 |
24-04-16 | 2,065 | -2.49% | 52,705 |
24-04-15 | 2,118 | +0.12% | 81,061 |
24-04-12 | 2,115 | -1.14% | 79,775 |
Delayed Quote NSE India S.E., April 19, 2024 at 07:43 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.08% | 3.13B | |
+20.91% | 43.54B | |
+16.96% | 21.74B | |
+9.05% | 13.53B | |
+7.98% | 13.02B | |
+33.80% | 11.28B | |
-11.05% | 6.99B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+6.64% | 5.09B |
- Stock Market
- Equities
- AJANTPHARM Stock